Recent Finacing
Recent Raise
NASH is a Dutch biotech developing a therapeutic candidate for non-alcoholic steatohepatitis, led by Dezima’s former CEO and preparing to enter Phase IIb clinical development.
This company doesn't have industry or investor information available.
Total Raised
Funding round